Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

ReutersReuters2026/09/14 00:39
  • Franco-Nevada agreed to buy a A$170 million gross royalty from Minerals 260 over the Bullabulling Gold Project in Western Australia.
  • The deal adds a 1.45% gross royalty, lifting its effective interest to 3.9% over Bullabulling.
  • The royalty steps down to 2.75% once 6 million ounces of gold are produced from royalty lands.
  • The area of interest expands to 10 km from the prior boundary, extending coverage to about 650 km2.
  • Closing payment is expected from cash on hand; the transaction was announced Sept. 13, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Franco-Nevada Corporation published the original content used to generate this news brief via CNW (Ref. ID: 202609132038CANADANWCANADAPR_C4494) on September 14, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas